Trial Profile
1145A Phase 2, Open-Label, Multi-Center, Randomized Trial To Demonstrate The Pharmacokinetics Of LCP-Tacro Tablets Once Daily and Prograf Capsules Twice Daily In Adult De Novo Kidney Transplant Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 03 Jul 2012 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 03 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 May 2011 Results presented at the American Transplant Congress -- 11th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.